New

Gram-positive Bacterial Infections Market

2021

Gram-positive Bacterial Infections Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease (Methicillin-resistant Staphylococcus aureus (MRSA), Pneumonia, Sepsis, Sinusitis, Skin Disorders, Other Diseases); Drug Type (Antibiotic, Antifungal, Others); Route of Administration (Enteral, Parenteral, Others); Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Other Distribution Channels) and Geography

| Report Code: TIPRE00004059 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Gram-positive Bacterial Infections Market 2028 By Disease, Drug Type, Route of Administration, Distribution Channel and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW



Gram-positive bacteria are known as the leading class of bacteria to cause infectious diseases in humans. These bacteria retain gram stain because of which are observed as violet purple colored stains when observed under the microscope. Infections caused due to gram positive bacteria are acquired through various source. They are known to cause infections such as,sepsis, pneumonia, and MRSA, among others. Because of their highly infectious nature, treatment of gram positive infections has been an area of focus during the recent years. And various approches are been developed to manage infections caused due to gram positive bacteria.

MARKET SCOPE



The "Global Gram-Positive Bacterial Infections Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the gram-positive bacterial infections market with detailed market segmentation by disease, drug type, route of administration and distribution channel. The report provides key statistics on the market status of the leading gram-positive bacterial infections market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  • Based on disease the market is segmented as, Methicillin-Resistant Staphylococcus Aureus (MRSA), pneumonia, sepsis, sinusitis, skin disorders and other diseases.
  • Based on drug type the market is segmented as, antibiotic, antifungal and others.
  • Based on route of administration the market is segmented as, enteral, parenteral and others.
  • Based on distribution channel the market is segmented as, hospital pharmacies, drug stores and retail pharmacies and other distribution channels.

MARKET DYNAMICS


Drivers:



  • Increasing prevalence of infections caused by gram positive bacteria.
  • Increasing awareness regarding management of infectious diseases.
  • Ongoing R&D studies by pharmaceutical companies to develop therapies for management of gram positive bacterial infections.

Restraints:



  • However, risk of side effects due to prolonged drug therapy is likely to restrain market growth during the forecast period.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The gram-positive bacterial infections market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the gram-positive bacterial infections market in these regions.

IMPACT OF COVID-19 ON GRAM-POSITIVE BACTERIAL INFECTIONS MARKET



COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS



The report covers key developments in the gram-positive bacterial infections market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from gram-positive bacterial infections market are anticipated to lucrative growth opportunities in the future with the rising demand for gram-positive bacterial infections in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the gram-positive bacterial infections market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  • Abbvie
  • AstraZeneca
  • Bayer AG
  • GlaxoSmithKline plc.
  • Merck Sharp and Dohme Corp.
  • NovaBiotics Ltd
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Dr. Reddy's Laboratories Inc
    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
  • TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Gram-positive Bacterial Infections Market - By Disease
    1.3.2 Gram-positive Bacterial Infections Market - By Drug Type
    1.3.3 Gram-positive Bacterial Infections Market - By Route of Administration
    1.3.4 Gram-positive Bacterial Infections Market - By Distribution Channel
    1.3.5 Gram-positive Bacterial Infections Market - By Region
    1.3.5.1 By Country

    2. KEY TAKEAWAYS

    3. RESEARCH METHODOLOGY

    4. GRAM-POSITIVE BACTERIAL INFECTIONS MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PORTER'S FIVE FORCES ANALYSIS
    4.2.1 Bargaining Power of Buyers
    4.2.1 Bargaining Power of Suppliers
    4.2.1 Threat of Substitute
    4.2.1 Threat of New Entrants
    4.2.1 Competitive Rivalry
    4.3. EXPERT OPINIONS

    5. GRAM-POSITIVE BACTERIAL INFECTIONS MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

    6. GRAM-POSITIVE BACTERIAL INFECTIONS MARKET - GLOBAL MARKET ANALYSIS
    6.1. GRAM-POSITIVE BACTERIAL INFECTIONS - GLOBAL MARKET OVERVIEW
    6.2. GRAM-POSITIVE BACTERIAL INFECTIONS - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE

    7. GRAM-POSITIVE BACTERIAL INFECTIONS MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE
    7.1. OVERVIEW
    7.2. DISEASE MARKET FORECASTS AND ANALYSIS
    7.3. METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA)
    7.3.1. Overview
    7.3.2. Methicillin-resistant Staphylococcus aureus (MRSA) Market Forecast and Analysis
    7.4. PNEUMONIA
    7.4.1. Overview
    7.4.2. Pneumonia Market Forecast and Analysis
    7.5. SEPSIS
    7.5.1. Overview
    7.5.2. Sepsis Market Forecast and Analysis
    7.6. SINUSITIS
    7.6.1. Overview
    7.6.2. Sinusitis Market Forecast and Analysis
    7.7. SKIN DISORDERS
    7.7.1. Overview
    7.7.2. Skin Disorders Market Forecast and Analysis
    7.8. OTHER DISEASES
    7.8.1. Overview
    7.8.2. Other Diseases Market Forecast and Analysis
    8. GRAM-POSITIVE BACTERIAL INFECTIONS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
    8.1. OVERVIEW
    8.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
    8.3. ANTIBIOTIC
    8.3.1. Overview
    8.3.2. Antibiotic Market Forecast and Analysis
    8.4. ANTIFUNGAL
    8.4.1. Overview
    8.4.2. Antifungal Market Forecast and Analysis
    8.5. OTHERS
    8.5.1. Overview
    8.5.2. Others Market Forecast and Analysis
    9. GRAM-POSITIVE BACTERIAL INFECTIONS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
    9.1. OVERVIEW
    9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
    9.3. ENTERAL
    9.3.1. Overview
    9.3.2. Enteral Market Forecast and Analysis
    9.4. PARENTERAL
    9.4.1. Overview
    9.4.2. Parenteral Market Forecast and Analysis
    9.5. OTHERS
    9.5.1. Overview
    9.5.2. Others Market Forecast and Analysis
    10. GRAM-POSITIVE BACTERIAL INFECTIONS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
    10.1. OVERVIEW
    10.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
    10.3. HOSPITAL PHARMACIES
    10.3.1. Overview
    10.3.2. Hospital Pharmacies Market Forecast and Analysis
    10.4. DRUG STORES AND RETAIL PHARMACIES
    10.4.1. Overview
    10.4.2. Drug Stores and Retail Pharmacies Market Forecast and Analysis
    10.5. OTHER DISTRIBUTION CHANNELS
    10.5.1. Overview
    10.5.2. Other Distribution Channels Market Forecast and Analysis

    11. GRAM-POSITIVE BACTERIAL INFECTIONS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    11.1. NORTH AMERICA
    11.1.1 North America Gram-positive Bacterial Infections Market Overview
    11.1.2 North America Gram-positive Bacterial Infections Market Forecasts and Analysis
    11.1.3 North America Gram-positive Bacterial Infections Market Forecasts and Analysis - By Disease
    11.1.4 North America Gram-positive Bacterial Infections Market Forecasts and Analysis - By Drug Type
    11.1.5 North America Gram-positive Bacterial Infections Market Forecasts and Analysis - By Route of Administration
    11.1.6 North America Gram-positive Bacterial Infections Market Forecasts and Analysis - By Distribution Channel
    11.1.7 North America Gram-positive Bacterial Infections Market Forecasts and Analysis - By Countries
    11.1.7.1 United States Gram-positive Bacterial Infections Market
    11.1.7.1.1 United States Gram-positive Bacterial Infections Market by Disease
    11.1.7.1.2 United States Gram-positive Bacterial Infections Market by Drug Type
    11.1.7.1.3 United States Gram-positive Bacterial Infections Market by Route of Administration
    11.1.7.1.4 United States Gram-positive Bacterial Infections Market by Distribution Channel
    11.1.7.2 Canada Gram-positive Bacterial Infections Market
    11.1.7.2.1 Canada Gram-positive Bacterial Infections Market by Disease
    11.1.7.2.2 Canada Gram-positive Bacterial Infections Market by Drug Type
    11.1.7.2.3 Canada Gram-positive Bacterial Infections Market by Route of Administration
    11.1.7.2.4 Canada Gram-positive Bacterial Infections Market by Distribution Channel
    11.1.7.3 Mexico Gram-positive Bacterial Infections Market
    11.1.7.3.1 Mexico Gram-positive Bacterial Infections Market by Disease
    11.1.7.3.2 Mexico Gram-positive Bacterial Infections Market by Drug Type
    11.1.7.3.3 Mexico Gram-positive Bacterial Infections Market by Route of Administration
    11.1.7.3.4 Mexico Gram-positive Bacterial Infections Market by Distribution Channel
    11.2. EUROPE
    11.2.1 Europe Gram-positive Bacterial Infections Market Overview
    11.2.2 Europe Gram-positive Bacterial Infections Market Forecasts and Analysis
    11.2.3 Europe Gram-positive Bacterial Infections Market Forecasts and Analysis - By Disease
    11.2.4 Europe Gram-positive Bacterial Infections Market Forecasts and Analysis - By Drug Type
    11.2.5 Europe Gram-positive Bacterial Infections Market Forecasts and Analysis - By Route of Administration
    11.2.6 Europe Gram-positive Bacterial Infections Market Forecasts and Analysis - By Distribution Channel
    11.2.7 Europe Gram-positive Bacterial Infections Market Forecasts and Analysis - By Countries
    11.2.7.1 Germany Gram-positive Bacterial Infections Market
    11.2.7.1.1 Germany Gram-positive Bacterial Infections Market by Disease
    11.2.7.1.2 Germany Gram-positive Bacterial Infections Market by Drug Type
    11.2.7.1.3 Germany Gram-positive Bacterial Infections Market by Route of Administration
    11.2.7.1.4 Germany Gram-positive Bacterial Infections Market by Distribution Channel
    11.2.7.2 France Gram-positive Bacterial Infections Market
    11.2.7.2.1 France Gram-positive Bacterial Infections Market by Disease
    11.2.7.2.2 France Gram-positive Bacterial Infections Market by Drug Type
    11.2.7.2.3 France Gram-positive Bacterial Infections Market by Route of Administration
    11.2.7.2.4 France Gram-positive Bacterial Infections Market by Distribution Channel
    11.2.7.3 Italy Gram-positive Bacterial Infections Market
    11.2.7.3.1 Italy Gram-positive Bacterial Infections Market by Disease
    11.2.7.3.2 Italy Gram-positive Bacterial Infections Market by Drug Type
    11.2.7.3.3 Italy Gram-positive Bacterial Infections Market by Route of Administration
    11.2.7.3.4 Italy Gram-positive Bacterial Infections Market by Distribution Channel
    11.2.7.4 Spain Gram-positive Bacterial Infections Market
    11.2.7.4.1 Spain Gram-positive Bacterial Infections Market by Disease
    11.2.7.4.2 Spain Gram-positive Bacterial Infections Market by Drug Type
    11.2.7.4.3 Spain Gram-positive Bacterial Infections Market by Route of Administration
    11.2.7.4.4 Spain Gram-positive Bacterial Infections Market by Distribution Channel
    11.2.7.5 United Kingdom Gram-positive Bacterial Infections Market
    11.2.7.5.1 United Kingdom Gram-positive Bacterial Infections Market by Disease
    11.2.7.5.2 United Kingdom Gram-positive Bacterial Infections Market by Drug Type
    11.2.7.5.3 United Kingdom Gram-positive Bacterial Infections Market by Route of Administration
    11.2.7.5.4 United Kingdom Gram-positive Bacterial Infections Market by Distribution Channel
    11.2.7.6 Rest of Europe Gram-positive Bacterial Infections Market
    11.2.7.6.1 Rest of Europe Gram-positive Bacterial Infections Market by Disease
    11.2.7.6.2 Rest of Europe Gram-positive Bacterial Infections Market by Drug Type
    11.2.7.6.3 Rest of Europe Gram-positive Bacterial Infections Market by Route of Administration
    11.2.7.6.4 Rest of Europe Gram-positive Bacterial Infections Market by Distribution Channel
    11.3. ASIA-PACIFIC
    11.3.1 Asia-Pacific Gram-positive Bacterial Infections Market Overview
    11.3.2 Asia-Pacific Gram-positive Bacterial Infections Market Forecasts and Analysis
    11.3.3 Asia-Pacific Gram-positive Bacterial Infections Market Forecasts and Analysis - By Disease
    11.3.4 Asia-Pacific Gram-positive Bacterial Infections Market Forecasts and Analysis - By Drug Type
    11.3.5 Asia-Pacific Gram-positive Bacterial Infections Market Forecasts and Analysis - By Route of Administration
    11.3.6 Asia-Pacific Gram-positive Bacterial Infections Market Forecasts and Analysis - By Distribution Channel
    11.3.7 Asia-Pacific Gram-positive Bacterial Infections Market Forecasts and Analysis - By Countries
    11.3.7.1 Australia Gram-positive Bacterial Infections Market
    11.3.7.1.1 Australia Gram-positive Bacterial Infections Market by Disease
    11.3.7.1.2 Australia Gram-positive Bacterial Infections Market by Drug Type
    11.3.7.1.3 Australia Gram-positive Bacterial Infections Market by Route of Administration
    11.3.7.1.4 Australia Gram-positive Bacterial Infections Market by Distribution Channel
    11.3.7.2 China Gram-positive Bacterial Infections Market
    11.3.7.2.1 China Gram-positive Bacterial Infections Market by Disease
    11.3.7.2.2 China Gram-positive Bacterial Infections Market by Drug Type
    11.3.7.2.3 China Gram-positive Bacterial Infections Market by Route of Administration
    11.3.7.2.4 China Gram-positive Bacterial Infections Market by Distribution Channel
    11.3.7.3 India Gram-positive Bacterial Infections Market
    11.3.7.3.1 India Gram-positive Bacterial Infections Market by Disease
    11.3.7.3.2 India Gram-positive Bacterial Infections Market by Drug Type
    11.3.7.3.3 India Gram-positive Bacterial Infections Market by Route of Administration
    11.3.7.3.4 India Gram-positive Bacterial Infections Market by Distribution Channel
    11.3.7.4 Japan Gram-positive Bacterial Infections Market
    11.3.7.4.1 Japan Gram-positive Bacterial Infections Market by Disease
    11.3.7.4.2 Japan Gram-positive Bacterial Infections Market by Drug Type
    11.3.7.4.3 Japan Gram-positive Bacterial Infections Market by Route of Administration
    11.3.7.4.4 Japan Gram-positive Bacterial Infections Market by Distribution Channel
    11.3.7.5 South Korea Gram-positive Bacterial Infections Market
    11.3.7.5.1 South Korea Gram-positive Bacterial Infections Market by Disease
    11.3.7.5.2 South Korea Gram-positive Bacterial Infections Market by Drug Type
    11.3.7.5.3 South Korea Gram-positive Bacterial Infections Market by Route of Administration
    11.3.7.5.4 South Korea Gram-positive Bacterial Infections Market by Distribution Channel
    11.3.7.6 Rest of Asia-Pacific Gram-positive Bacterial Infections Market
    11.3.7.6.1 Rest of Asia-Pacific Gram-positive Bacterial Infections Market by Disease
    11.3.7.6.2 Rest of Asia-Pacific Gram-positive Bacterial Infections Market by Drug Type
    11.3.7.6.3 Rest of Asia-Pacific Gram-positive Bacterial Infections Market by Route of Administration
    11.3.7.6.4 Rest of Asia-Pacific Gram-positive Bacterial Infections Market by Distribution Channel
    11.4. MIDDLE EAST AND AFRICA
    11.4.1 Middle East and Africa Gram-positive Bacterial Infections Market Overview
    11.4.2 Middle East and Africa Gram-positive Bacterial Infections Market Forecasts and Analysis
    11.4.3 Middle East and Africa Gram-positive Bacterial Infections Market Forecasts and Analysis - By Disease
    11.4.4 Middle East and Africa Gram-positive Bacterial Infections Market Forecasts and Analysis - By Drug Type
    11.4.5 Middle East and Africa Gram-positive Bacterial Infections Market Forecasts and Analysis - By Route of Administration
    11.4.6 Middle East and Africa Gram-positive Bacterial Infections Market Forecasts and Analysis - By Distribution Channel
    11.4.7 Middle East and Africa Gram-positive Bacterial Infections Market Forecasts and Analysis - By Countries
    11.4.7.1 South Africa Gram-positive Bacterial Infections Market
    11.4.7.1.1 South Africa Gram-positive Bacterial Infections Market by Disease
    11.4.7.1.2 South Africa Gram-positive Bacterial Infections Market by Drug Type
    11.4.7.1.3 South Africa Gram-positive Bacterial Infections Market by Route of Administration
    11.4.7.1.4 South Africa Gram-positive Bacterial Infections Market by Distribution Channel
    11.4.7.2 Saudi Arabia Gram-positive Bacterial Infections Market
    11.4.7.2.1 Saudi Arabia Gram-positive Bacterial Infections Market by Disease
    11.4.7.2.2 Saudi Arabia Gram-positive Bacterial Infections Market by Drug Type
    11.4.7.2.3 Saudi Arabia Gram-positive Bacterial Infections Market by Route of Administration
    11.4.7.2.4 Saudi Arabia Gram-positive Bacterial Infections Market by Distribution Channel
    11.4.7.3 U.A.E Gram-positive Bacterial Infections Market
    11.4.7.3.1 U.A.E Gram-positive Bacterial Infections Market by Disease
    11.4.7.3.2 U.A.E Gram-positive Bacterial Infections Market by Drug Type
    11.4.7.3.3 U.A.E Gram-positive Bacterial Infections Market by Route of Administration
    11.4.7.3.4 U.A.E Gram-positive Bacterial Infections Market by Distribution Channel
    11.4.7.4 Rest of Middle East and Africa Gram-positive Bacterial Infections Market
    11.4.7.4.1 Rest of Middle East and Africa Gram-positive Bacterial Infections Market by Disease
    11.4.7.4.2 Rest of Middle East and Africa Gram-positive Bacterial Infections Market by Drug Type
    11.4.7.4.3 Rest of Middle East and Africa Gram-positive Bacterial Infections Market by Route of Administration
    11.4.7.4.4 Rest of Middle East and Africa Gram-positive Bacterial Infections Market by Distribution Channel
    11.5. SOUTH AND CENTRAL AMERICA
    11.5.1 South and Central America Gram-positive Bacterial Infections Market Overview
    11.5.2 South and Central America Gram-positive Bacterial Infections Market Forecasts and Analysis
    11.5.3 South and Central America Gram-positive Bacterial Infections Market Forecasts and Analysis - By Disease
    11.5.4 South and Central America Gram-positive Bacterial Infections Market Forecasts and Analysis - By Drug Type
    11.5.5 South and Central America Gram-positive Bacterial Infections Market Forecasts and Analysis - By Route of Administration
    11.5.6 South and Central America Gram-positive Bacterial Infections Market Forecasts and Analysis - By Distribution Channel
    11.5.7 South and Central America Gram-positive Bacterial Infections Market Forecasts and Analysis - By Countries
    11.5.7.1 Brazil Gram-positive Bacterial Infections Market
    11.5.7.1.1 Brazil Gram-positive Bacterial Infections Market by Disease
    11.5.7.1.2 Brazil Gram-positive Bacterial Infections Market by Drug Type
    11.5.7.1.3 Brazil Gram-positive Bacterial Infections Market by Route of Administration
    11.5.7.1.4 Brazil Gram-positive Bacterial Infections Market by Distribution Channel
    11.5.7.2 Argentina Gram-positive Bacterial Infections Market
    11.5.7.2.1 Argentina Gram-positive Bacterial Infections Market by Disease
    11.5.7.2.2 Argentina Gram-positive Bacterial Infections Market by Drug Type
    11.5.7.2.3 Argentina Gram-positive Bacterial Infections Market by Route of Administration
    11.5.7.2.4 Argentina Gram-positive Bacterial Infections Market by Distribution Channel
    11.5.7.3 Rest of South and Central America Gram-positive Bacterial Infections Market
    11.5.7.3.1 Rest of South and Central America Gram-positive Bacterial Infections Market by Disease
    11.5.7.3.2 Rest of South and Central America Gram-positive Bacterial Infections Market by Drug Type
    11.5.7.3.3 Rest of South and Central America Gram-positive Bacterial Infections Market by Route of Administration
    11.5.7.3.4 Rest of South and Central America Gram-positive Bacterial Infections Market by Distribution Channel

    12. INDUSTRY LANDSCAPE
    12.1. MERGERS AND ACQUISITIONS
    12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    12.3. NEW PRODUCT LAUNCHES
    12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

    13. GRAM-POSITIVE BACTERIAL INFECTIONS MARKET, KEY COMPANY PROFILES
    13.1. ABBVIE
    13.1.1. Key Facts
    13.1.2. Business Description
    13.1.3. Products and Services
    13.1.4. Financial Overview
    13.1.5. SWOT Analysis
    13.1.6. Key Developments
    13.2. ASTRAZENECA
    13.2.1. Key Facts
    13.2.2. Business Description
    13.2.3. Products and Services
    13.2.4. Financial Overview
    13.2.5. SWOT Analysis
    13.2.6. Key Developments
    13.3. BAYER AG
    13.3.1. Key Facts
    13.3.2. Business Description
    13.3.3. Products and Services
    13.3.4. Financial Overview
    13.3.5. SWOT Analysis
    13.3.6. Key Developments
    13.4. GLAXOSMITHKLINE PLC.
    13.4.1. Key Facts
    13.4.2. Business Description
    13.4.3. Products and Services
    13.4.4. Financial Overview
    13.4.5. SWOT Analysis
    13.4.6. Key Developments
    13.5. MERCK SHARP AND DOHME CORP.
    13.5.1. Key Facts
    13.5.2. Business Description
    13.5.3. Products and Services
    13.5.4. Financial Overview
    13.5.5. SWOT Analysis
    13.5.6. Key Developments
    13.6. NOVABIOTICS LTD
    13.6.1. Key Facts
    13.6.2. Business Description
    13.6.3. Products and Services
    13.6.4. Financial Overview
    13.6.5. SWOT Analysis
    13.6.6. Key Developments
    13.7. NOVARTIS AG
    13.7.1. Key Facts
    13.7.2. Business Description
    13.7.3. Products and Services
    13.7.4. Financial Overview
    13.7.5. SWOT Analysis
    13.7.6. Key Developments
    13.8. PFIZER INC.
    13.8.1. Key Facts
    13.8.2. Business Description
    13.8.3. Products and Services
    13.8.4. Financial Overview
    13.8.5. SWOT Analysis
    13.8.6. Key Developments
    13.9. SANOFI
    13.9.1. Key Facts
    13.9.2. Business Description
    13.9.3. Products and Services
    13.9.4. Financial Overview
    13.9.5. SWOT Analysis
    13.9.6. Key Developments
    13.10. DR. REDDY'S LABORATORIES INC
    13.10.1. Key Facts
    13.10.2. Business Description
    13.10.3. Products and Services
    13.10.4. Financial Overview
    13.10.5. SWOT Analysis
    13.10.6. Key Developments

    14. APPENDIX
    14.1. ABOUT THE INSIGHT PARTNERS
    14.2. GLOSSARY OF TERMS
    The List of Companies

    - Abbvie
    - AstraZeneca
    - Bayer AG
    - GlaxoSmithKline plc.
    - Merck Sharp and Dohme Corp.
    - NovaBiotics Ltd
    - Novartis AG
    - Pfizer Inc.
    - Sanofi
    - Dr. Reddy's Laboratories Inc
    - Cipla
    - Alembic Pharmaceuticals
    - Mankind Pharma
    - Intas
    TIPRE00004059
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Pricing

    Free

    20%

    customization on Pre-Booking
    Request for Sample
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.